Linopirdine is a putative cognition-enhancing drug with a novel mechanism of action. Linopirdine blocks the KCNQ23 heteromer M current with an IC50 of 2.4nM disinhibiting acetylcholine release and increasing hippocampal CA3-schaffer collateral mediated glutamate release onto CA1 pyramidal neurons.
This page contains content from the copyrighted Wikipedia article "Linopirdine"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
